Join Us | BOOTH 258
Entegris helps advanced therapy innovators build clean, scalable, and contamination-resilient processes from the start. With semiconductor-grade purity and advanced particle detection, we reduce development risk - so every breakthrough is Pure, Proven, and Precise. Meet with our experts and learn how Entegris can strengthen your workflow!
Featured Presentation
BUILDING SCALABLE CELL THERAPY WORKFLOWS: MEDIA, PROCESS, AND AUTOMATION IN ACTION
February 11 | 8:00-9:00 A.M.
Are you ready to simplify your MSC workflow? Would you like a reliable, scale-up-ready solution to support your MSC therapy development? The road from early discovery to commercial manufacturing is rarely linear. Cell and gene therapies fail to scale when early media and material selection do not survive tech transfer. Media formulation choices, raw material strategy and process design in early development have a direct impact on scale-up success, cost of goods, and regulatory readiness.
Explore how to design a right-first time workflow with integrated cell culture media, process liquids, development services and automation solutions can de-risk tech transfer and accelerate time-to-patient.
WHAT TO EXPECT:
Part 1:
The panel brings industry experts together to highlight how smart early development choices can set the stage for smoother tech transfer, stronger clinical outcomes, and commercial success.
- Current challenges in MSC therapy development
Reducing variability in raw material and donor selection - Building GMP considerations into early development
- Transitioning from bottles to closed bag systems, moving to automation
- Preparing processes for commercial manufacturing
Part 2:
The panel answers audience questions with an interactive Q&A.
Presenter:
Jeff Shumway
Principal Account Manager, North America Sales
Event Related Content
Our Life Sciences Technology Center is your gateway to cutting-edge freeze/thaw technology and support. We provide everything needed to make educated decisions about what freezing process and products best fit your needs.
Entegris, a world-class supplier of advanced materials and process solutions for the semiconductor industry, brings over 50 years of contamination control expertise and supply chain strength to life sciences customers around the world. Our technologies help improve purity and yield in a wide range of pharmaceutical applications including COVID-19 vaccine manufacturing.
Aramus™ 2D single-use bags provide high purity, exceptional compatibility, and increased safety for critical process fluids and final products. These robust products are now available in custom shapes, sizes, and assembly configurations to optimize your process.
Many C> treatments such as CAR-T and mRNA vaccines require repeated freezing and thawing during production, storage, and delivery. Aramus™ single-use assemblies are ideal for protecting and optimizing the cold-chain freeze/thaw processes for these precious treatments.